Oceania Healthcare Ltd.

As of March 31, 2026, Oceania Healthcare Ltd. carries a market capitalization of 469.26M, placing it among publicly traded companies globally. Its enterprise value stands at 894.08M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Oceania Healthcare Ltd.'s next confirmed earnings release is scheduled for November 30, 2026.

As of March 31, 2026, Oceania Healthcare Ltd. has 724.23M shares outstanding.

As of March 31, 2026, Oceania Healthcare Ltd. trades at a trailing price-to-earnings ratio of 4,736.12. The price-to-sales ratio is 2.11, and the price-to-book ratio stands at 0.48.

As of March 31, 2026, Oceania Healthcare Ltd. trades at an EV/EBITDA multiple of 97.31 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 4.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 894.08M versus a market cap of 469.26M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Oceania Healthcare Ltd. maintains a current ratio of 0.11, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 44.72, indicating elevated leverage, while an interest coverage ratio of 0.44 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Oceania Healthcare Ltd. posted a return on equity (ROE) of 0.01, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 0.00, measuring how efficiently the asset base is converted into earnings. The company generates approximately 99,031.37 in revenue per employee across its workforce of 2,246.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended March 31, 2026, Oceania Healthcare Ltd. recorded an income tax benefit of -6.52M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -6.42M and 99,081.42 in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 20, 2026, Oceania Healthcare Ltd.'s stock has declined approximately 11.48% over the past 52 weeks. The 50-day moving average sits at 0.62, while the 200-day moving average is 0.65.

Over the twelve months ended March 31, 2026, Oceania Healthcare Ltd. generated 222.42M in revenue and converted that into 99,081.42 in net income, yielding earnings per share of 0.00. EBITDA reached 9.19M, while operating income came in at -12.59M.

As of March 31, 2026, Oceania Healthcare Ltd. holds 13.81M in cash and equivalents against 438.63M in total debt, resulting in a net debt position of 416.45M. Total book value stands at 980.77M, with working capital of -1.01B providing operational flexibility.

These figures cover the twelve months ended March 31, 2026.

These figures cover the twelve months ended March 31, 2026. The operating margin of -5.66 and net profit margin of 0.04 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Total shareholder yield reaches 20.47, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Oceania Healthcare Ltd. shareholders.

As of March 31, 2026, Oceania Healthcare Ltd. has an Altman Z-Score of -0.22, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.